Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes.

Giada Bianchetti Chiara Maria Assunta CefaloCarla FerreriAnna SansoneMarilena VitaleCassandra SerantoniAlessio AbeltinoTeresa MezzaPietro Manuel FerraroMarco De SpiritoGabriele RiccardiAndrea Giaccari Giuseppe Maulucci

Published in: European journal of clinical investigation (2023)

Increased membrane fluidity is associated with a higher CV risk in subjects with T2D. If confirmed in prospective studies, membrane fluidity could be a new biomarker for residual CV risk assessment in T2D.

Keyphrases

type diabetes
risk assessment
cardiovascular disease
heavy metals
human health
insulin resistance
glycemic control
adipose tissue
climate change